Epitope shared by functional variant of organic cation/carnitine transporter, OCTN1, Campylobacter jejuni and Mycobacterium paratuberculosis may underlie susceptibility to Crohn's disease at 5q31

Biochemical and Biophysical Research Communications

Volumn 337, Issue 4, 2005, Pages 1165-1175

  Lamhonwah, Anne Marie ^a,b   Ackerley, Cameron ^a   Onizuka, Russell ^a,b   Tilups, Aina ^a   Lamhonwah, Daniel ^a,b   Chung, Cilla ^a,b   Ke, Sheng Tao ^b   Tellier, Raymond ^a,b   Tein, Ingrid ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Crohn's disease; Inflammatory bowel disease; Mycobacterium paratuberculosis; OCTN1 Campylobacter jejuni; Organic cation carnitine transporter

Indexed keywords

AMINO ACID DERIVATIVE; CARNITINE DERIVATIVE; EPITOPE; ISOPROTEIN; LEUCINE; ORGANIC CATION TRANSPORTER; PHENYLALANINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAMPYLOBACTER JEJUNI; CHROMOSOME 5Q; COLON DISEASE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; GENE FUNCTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; ILEUM DISEASE; JEW; MOUSE; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PROTEIN TRANSPORT; RACE;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CACO-2 CELLS; CAMPYLOBACTER JEJUNI; CARRIER PROTEINS; CHROMOSOMES, HUMAN, PAIR 5; CROHN DISEASE; DISEASE SUSCEPTIBILITY; EPITOPES; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM PARATUBERCULOSIS; ORGANIC CATION TRANSPORT PROTEINS; SEQUENCE ALIGNMENT;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER JEJUNI; MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS;

EID: 27144467098     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.09.170     Document Type: Article

References (73)

1. J. Bremer Carnitine-metabolism and functions Physiol. Rev. 63 1983 1420 1480
2. X. Wu, P.D. Prasad, F.H. Leibach, and V. Ganapathy cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family Biochem. Biophys. Res. Commun. 246 1998 589 595
3. I. Tamai, R. Ohashi, J. Nezu, H. Yabuuchi, A. Oku, M. Shimane, Y. Sai, and A. Tsuji Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2 J. Biol. Chem. 273 1998 20378 20382
4. A.M. Lamhonwah, and I. Tein Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transporter gene Biochem. Biophys. Res. Commun. 252 1998 396 401
5. J. Nezu, I. Tamai, A. Oku, R. Ohashi, H. Yabuuchi, N. Hashimoto, H. Nikaido, Y. Sai, A. Koizumi, Y. Shoji, G. Takada, T. Matsuishi, M. Yoshino, H. Kato, T. Ohura, G. Tsujimoto, J. Hayakawa, M. Shimane, and A. Tsuji Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter Nat. Genet. 21 1999 91 94
6. N.L. Tang, V. Ganapathy, X. Wu, J. Hui, P. Seth, P.M. Yuen, R.J. Wanders, T.F. Fok, and N.M. Hjelm Mutations of OCTN2, an organic cation/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency Hum. Mol. Genet. 8 1999 655 660
7. A.M. Lamhonwah, S.E. Olpin, R.J. Pollitt, C. Vianey-Saban, P. Divry, N. Guffon, G.T.N. Besley, R. Onizuka, L.J. DeMeirleir, L. Cvitanovic-Sojat, I. Baric, C. Dionisi-Vici, K. Fumic, M. Maradin, and I. Tein Novel OCTN2 mutations: no genotype-phenotype correlations. Early carnitine therapy prevents cardiomyopathy Am. J. Med. Genet. 111 2002 271 284
8. I. Tein, D.C. De Vivo, F. Bierman, P. Pulver, L.J. De Meirleir, L. Cvitanovic-Sojat, R.A. Pagon, E. Bertini, C. Dionisi-Vici, S. Servidei, and S. DiMauro Impaired skin fibroblast carnitine uptake in primary systemic carnitine deficiency manifested by childhood carnitine-responsive cardiomyopathy Pediatr. Res. 28 1990 247 255
9. C.A. Stanley, S. DeLeeuw, P.M. Coates, C. Vianey-Liaud, P. Divry, J.P. Bonnefont, J.M. Saudubray, M. Haymond, F.K. Trefz, G.N. Breningstall, R.S. Wappner, D.J. Byrd, C. Sansaricq, I. Tein, W. Grover, D. Valle, S.L. Rutledge, and W.R. Treem Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake Ann. Neurol. 30 1991 709 716
10. J. Bahl, T. Navin, A. Manian, and R. Bressler Carnitine transport in isolated adult rat heart myocytes and the effect of 7,8,-diOH chlorpromazine Circ. Res. 48 1981 378 385
11. C.J. Rebouche, and A.G. Engel Carnitine transport in cultured muscle cells and skin fibroblasts from patients with primary systemic carnitine deficiency In Vitro 18 1982 495 500
12. W.R. Treem, C.A. Stanley, D.N. Finegold, D.E. Hale, and P.M. Coates Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle and fibroblasts N. Engl. J. Med. 319 1988 1331 1336
13. R. Pons, R. Carrozzo, I. Tein, W.F. Walker, L.J. Addonizio, W. Rhead, A.F. Miranda, S. DiMauro, and D.C. De Vivo Deficient muscle carnitine transport in primary carnitine deficiency Pediatr. Res. 42 1997 583 587
14. M.J. James, D.E. Brooks, and A.M. Snoswell Kinetics of carnitine uptake by rat epididymal cells. Androgen-dependence and lack of stereospecificity FEBS Lett. 126 1981 53 56
15. J.W. Hamilton, B.U. Li, A.L. Shug, and W.A. Olsen Studies of l-carnitine absorption in man Gastroenterology 84 1983 1180
16. L.L. Bieber Carnitine Ann. Rev. Biochem. 57 1988 261 283
17. I. Tamai, R. Ohashi, J.I. Nezu, Y. Sai, D. Kobayashi, A. Oku, M. Shimane, and A. Tsuji Molecular and functional characterization of organic cation/carnitine transporter family in mice J. Biol. Chem. 275 2000 40064 40072
18. J.B. Pritchard, and D.S. Miller Mechanisms mediating renal secretion of organic anions and cations Physiol. Rev. 73 1983 765 796
19. K.J. Ullrich Specificity of transporters for 'organic anions' and 'organic cations' in the kidney Biochim. Biophys. Acta 1197 1994 45 62
20. S. Zevin, M.E. Schaner, N.P. Illsley, and K.M. Giacomini Guanidine transport in a human choriocarcinoma cell line (JAR) Pharm. Res. 14 1997 401 405
21. I. Tamai, H. Yabuuchi, J. Nezu, Y. Sai, A. Oku, M. Shimane, and A. Tsuji Cloning and characterization of a novel human pH-dependent organic cation transporter OCTN1 FEBS Lett. 419 1997 107 111
22. H. Yabuuchi, I. Tamai, J. Nezu, K. Sakamoto, A. Oku, M. Shimane, Y. Sai, and A. Tsuji Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations J. Pharm. Exp. Ther. 289 1999 768 773
23. X. Wu, W. Huang, P.D. Prasad, P. Seth, D.P. Rajan, F.H. Leibach, J. Chen, S.I. Conway, and V. Ganapathy Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter J. Pharm. Exp. Ther. 290 1999 1482 1492
24. R. Ohashi, I. Tamai, H. Yabuuchi, J.I. Nezu, A. Oku, Y. Sai, M. Shimane, and A. Tsuji Na (+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance J. Pharmacol. Exp. Ther. 291 1999 778 784
25. X. Wu, R.L. George, W. Huang, H. Wang, S.J. Conway, F.H. Leibach, and V. Ganapathy Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta Biochim. Biophys. Acta 1466 2000 315 327
26. S. Shivananda, J. Lennard-Jones, R. Logan, N. Fear, A. Price, L. Carpenter, and M. van Blankenstein Incidence of inflammatory bowel disease across Europe: is there a difference between north and south ? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD) Gut 39 1996 690 697
27. R.B. Sartor Pathogenesis and immune mechanisms of chronic inflammaory bowel diseases Am. J. Gastroenterol. 92 1997 5S 11S
28. J.D. Rioux, M.S. Silverberg, M.J. Daly, A.H. Steinhart, R.S. McLeod, A.M. Griffiths, T. Green, T.S. Brettin, V. Stone, S.B. Bull, A. Bitton, C.N. Williams, G.R. Greenberg, Z. Cohen, E.S. Lander, T.J. Hudson, and K.A. Siminovitch Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci Am. J. Hum. Genet. 66 2000 1863 1870
29. C. Giallourakis, M. Stoll, K. Miller, J. Hampe, E.S. Lander, M.J. Daly, S. Schreiber, and J.D. Rioux IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis Am. J. Hum. Genet. 73 2003 205 211
30. J.D. Rioux, M.J. Daly, M.S. Silverberg, K. Lindblad, H. Steinhart, Z. Cohen, T. Delmonte, K. Kocher, K. Miller, S. Guschwan, E.J. Kulbokas, S. O'Leary, E. Winchester, K. Dewar, T. Green, V. Stone, C. Chow, A. Cohen, D. Langelier, G. Lapointe, D. Gaudet, J. Faith, N. Branco, S.B. Bull, R.S. McLeod, A.M. Griffiths, A. Bitton, G.R. Greenberg, E.S. Lander, K.A. Siminovitch, and T.J. Hudson Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease Nat. Genet. 29 2001 223 228
31. V.D. Peltekova, R.F. Wintle, L.A. Rubin, C.I. Amos, Q. Huang, X. Gu, B. Newman, M. Van Oene, D. Cescon, G. Greenberg, A.M. Griffiths, P.H. St George-Hyslop, and K.A. Siminovitch Functional variants of OCTN cation transporter genes are associated with Crohn disease Nat. Genet. 36 2004 471 475
32. G. Burckhardt, and N.A. Wolff Structure of renal organic anion and cation transporters Am. J. Physiol. Renal Physiol. 278 2000 F853 F866
33. V. Ramensky, P. Bork, and S. Sunyaev Human non-synonymous SNPs: server and survey Nucleic Acids Res. 30 2000 3894 3900
34. A. Krogh, B. Larsson, G. von Heijne, and E.L. Sonnhammer Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes J. Mol. Biol. 305 2001 567 580
35. P.C. Ng, J.G. Henikoff, and S. Henikoff PHAT: a transmembrane-specific substitution matrix. Predicted hydrophobic and transmembrane Bioinformatics. 16 2000 760 766 Erratum in: Bioinformatics 17 (2001) 290
36. P. Seth, X. Wu, W. Huang, F.H. Leibach, and V. Ganapathy Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function J. Biol. Chem. 274 1999 33388 33392
37. W.E. Roediger, and S. Nance Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation Br. J. Exp. Pathol. 67 1986 773 782
38. P. Hahn, and M. Taller Ketone formation in the intestinal mucosa of infant rats Life Sci. 41 1987 1525 1528
39. Y.I. Kim Short-chain fatty acids in ulcerative colitis Nutr. Rev. 56 1998 17 24
40. W.E. Roediger What sequence of pathogenetic events leads to acute ulcerative colitis? Dis. Colon Rectum 31 1988 482 487
41. W.R. Thayer Jr., J.A. Coutu, R.J. Chiodini, H.J. Van Kruiningen, and R.S. Merkal Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease Dig. Dis. Sci. 29 1984 1080 1085
42. F.A. El-Zaatari, S.A. Naser, K. Hulten, P. Burch, and D.Y. Graham Characterization of Mycobacterium paratuberculosis p36 antigen and its seroreactivities in Crohn's disease Curr. Microbiol. 39 1999 115 119
43. A. Newman, and J.R. Lambert Campylobacter jejuni causing flare-up in inflammatory bowel disease Lancet 2 1980 919
44. L.S. Berberian, Y. Valles-Ayoub, L.K. Gordon, S.R. Targan, and J. Braun Expression of a novel autoantibody defined by the VH3-15 gene in inflammatory bowel disease and Campylobacter jejuni enterocolitis J. Immunol. 153 1994 3756 3763
45. A.M. Lamhonwah, J. Skaug, S.W. Scherer, and I. Tein A third human carnitine/organic cation transporter (OCTN3) as a candidate for the 5q31 Crohn's disease locus (IBD5) Biochem. Biophys. Res. Commun. 301 2003 98 101
46. I. Nachamkin Campylobacter and arcobacter P.R. Murray E.J. Baron J.H. Jorgensen M.A. Pfaller R.H. Yolken Manual of Clinical Microbiology eighth ed. 2003 ASM Press Washington, DC Chapter 57
47. R.R. Ramsay Carnitine and its role in acyl group metabolism Essays Biochem. 28 1994 47 61
48. V.A. Zammit Carnitine acyltransferases: functional significance of subcellular distribution and membrane topology Prog. Lipid Res. 38 1999 199 224
49. R.R. Ramsay The carnitine acyltransferases: modulators of acyl-CoA-dependent reactions Biochem. Soc. Trans. 28 2000 182 186
50. M.S. Murthy, and S.V. Pande Malonyl-CoA binding site and the overt carnitine palmitoyl-transferase activity reside on the opposite sides of the outer mitochondrial membrane Proc. Natl. Acad. Sci. USA 84 1987 378 382
51. S.V. Pande, and R. Parvin Carnitine-acylcarnitine translocase catalyzes an equilibrating unidirectional transport as well J. Biol. Chem. 255 1980 2994 3001
52. R.R. Ramsay, and P.K. Tubbs The effects of temperature and some inhibitors on the carnitine exchange system of heart mitochondria Eur. J. Biochem. 69 1976 299 303
53. M.T. Collins, G. Lisby, C. Moser, D. Chicks, S. Christensen, M. Reichelderfer, N. Hoiby, B.A. Harms, O.O. Thomsen, U. Skibsted, and V. Binder Results of multiple diagnostic tests for Mycobacterium avium subsp. paratuberculosis in patients with inflammatory bowel disease and in controls J. Clin. Microbiol. 38 2000 4373 4381
54. L.A. Sechi, M. Mura, E. Tanda, A. Lissia, G. Fadda, and S. Zanetti Mycobacterium avium sub. paratuberculosis in tissue samples of Crohn's disease patients New Microbiol. 27 2004 75 77
55. A. Lavy, E. Broide, S. Reif, D. Keter, Y. Niv, S. Odes, R. Eliakim, A. Halak, Y. Ron, J. Patz, A. Fich, Y. Villa, N. Arber, and T. Gilat Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study Dig. Liver Dis. 33 2001 472 476
56. M. Feeney, A. Ciegg, P. Winwood, and J. Snook A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group Lancet 350 1997 764 766
57. A. Patja, I. Davidkin, T. Kurki, M.J. Kallio, M. Valle, and H. Peltola Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up Pediatr. Infect. Dis. J. 19 2000 1127 1134
58. R.L. Davis, P. Kramarz, K. Bohlke, P. Benson, R.S. Thompson, J. Mullooly, S. Black, H. Shinefield, E. Lewis, J. Ward, S.M. Marcy, E. Eriksen, F. Destefano, and R. Chen Vaccine Safety Datalink Team. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project Arch. Pediatr. Adolesc. Med. 155 2001 354 359
59. V. Seagroatt, and M.J. Goldacre Crohn's disease, ulcerative colitis, and measles vaccine in an English population, 1979-1998 J. Epidemiol. Community Health 57 2003 883 887
60. F.A. Balzola, K. Khan, A. Pera, F. Bonino, R.E. Pounder, and A.J. Wakefield Measles IgM immunoreactivity in patients with inflammatory bowel disease Ital. J. Gastroenterol. Hepatol. 30 1998 378 382
61. H.J. Van Kruiningen, D.R. Mayo, E. Vanopdenbosch, C. Gower-Rousseau, A. Cortot, and J.F. Colombel Virus serology in familial Crohn disease Scand. J. Gastroenterol. 35 2000 403 407
62. J.T. Jabbour, and J.L. Sever Serum measles antibody titers in patients with subacute sclerosing panencephalitis, compared with parents and siblings J. Pediatr. 73 1968 905 907
63. S. Ghosh, E. Armitage, D. Wilson, P.D. Minor, and M.A. Afzal Detection of persistent measles virus infection in Crohn's disease: current status of experimental work Gut 48 2001 748 752
64. A.J. Wakefield, R.M. Pittilo, R. Sim, S.L. Cosby, J.R. Stephenson, A.P. Dhillon, and R.E. Pounder Evidence of persistent measles virus infection in Crohn's disease J. Med. Virol. 39 1993 345 353
65. A.J. Wakefield, R. Sim, A.N. Akbar, R.E. Pounder, and A.P. Dhillon In situ immune responses in Crohn's disease: a comparison with acute and persistent measles virus infection J. Med. Virol. 51 1997 90 100
66. M.A. Afzal, E. Armitage, J. Begley, M.L. Bentley, P.D. Minor, S. Ghosh, and A. Ferguson Absence of detectable measles virus genome sequence in inflammatory bowel disease tissues and peripheral blood lymphocytes J. Med. Virol. 55 1998 243 249
67. M.A. Afzal, E. Armitage, S. Ghosh, L.C. Williams, and P.D. Minor Further evidence of the absence of measles virus genome sequence in full thickness intestinal specimens from patients with Crohn's disease J. Med. Virol. 62 2000 377 382
68. M. Iizuka, O. Nakagomi, M. Chiba, S. Ueda, and O. Masamune Absence of measles virus in Crohn's disease Lancet 345 1995 199
69. Y. Haga, O. Funakoshi, K. Kuroe, K. Kanazawa, H. Nakajima, H. Saito, Y. Murata, A. Munakata, and Y. Yoshida Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction Gut 38 1996 211 215
70. N. Chadwick, I.J. Bruce, S. Schepelmann, R.E. Pounder, and A.J. Wakefield Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction J. Med. Virol. 55 1998 305 311
71. H. Kawashima, T. Mori, Y. Kashiwagi, K. Takekuma, A. Hoshika, and A. Wakefield Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism Dig. Dis. Sci. 45 2000 723 729
72. H. Yang, and J.I. Rotter Genetics of inflammatory bowel disease S.R. Targan F. Shanahan Inflammatory Bowel Disease: From Bench to Bedside 1994 Williams and Wilkins Baltimore 32 64
73. R.H. Duerr Genetics of inflammatory bowel disease Inflam. Bowel Dis. 2 1996 48 60